Document is current
Any future updates will be listed below
-
Authors
Oh, Bernice L. Z. https://orcid.org/0000-0001-6184-8935
Shimasaki, Noriko https://orcid.org/0000-0002-6506-2291
Coustan-Smith, Elaine
Chan, Esther
Poon, Limei
Lee, Shawn H. R.
Yeap, Frances
Tan, Lip Kun
Chai, Louis Y. A.
Le Bert, Nina https://orcid.org/0000-0003-0502-2527
Tan, Nicole
Bertoletti, Antonio https://orcid.org/0000-0002-2942-0485
Chen, Siew Peng
Del Bufalo, Francesca https://orcid.org/0000-0001-9643-3465
Becilli, Marco
Locatelli, Franco https://orcid.org/0000-0002-7976-3654
Yeoh, Allen E. J. https://orcid.org/0000-0002-6454-976X
Campana, Dario
-
Funding
Funding for this research was provided by:
MOH | National Medical Research Council (CSA/0053/2013, CSA/0053/2008, RTF/MOH/000616, RTF/MOH/000302, Singapore Translational Research (STaR) Award MOH-000708)
- License Information
-
More Information
Article History
Received: 10 April 2024
Accepted: 2 August 2024
First Online: 3 September 2024
Competing interests
: B.L.Z.O., N.S., E.C., L.P., S.H.R.L., F.Y., L.K.T., L.Y.A.C., N.T., S.P.C., F.D.B. and M.B. declare no competing interests. E.C.-S.’s spouse receives royalties for patents related to the development of CAR T cell technologies and is a scientific founder and stockholder of Nkarta Therapeutics and Medisix Therapeutics. N.L.B. is a co-inventor in a pending patent for a method to monitor virus-specific T cells in biological samples. A.B. is a co-inventor in a pending patent for a method to monitor virus-specific T cells in biological samples and is a cofounder of Lion TCR. F.L. has been a consultant for Amgen, Bellicum, Novimmune and Vertex and a speaker for BluebirdBio and Amgen. A.E.J.Y. has been a consultant for Amgen. D.C. receives royalties for patents related to the development of CAR T cell technologies and is a scientific founder and stockholder of Nkarta Therapeutics and Medisix Therapeutics.
